Headache LogoAHS Logo

Most Viewed Articles

FREE DOWNLOADS: Most Read Articles
 

Overwhelming popularity among current readers make the following articles a must-read:

Alternative Headache Treatments: Nutraceuticals, Behavioral and Physical Treatments
Christina Sun-Edelstein and Alexander Mauskop
Volume 51, No. 3, March 2011

Cluster Headache-Acute and Prophylactic Therapy
Avi Ashkenazi and Todd Schwedt
Volume 51, No. 2, February 2011

Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Richard B. Lipton, Walter F. Stewart, Seymour Diamond, Merle L. Diamond and Michael Reed
Volume 41, No. 7, July/August 2001

The Challenge of New Daily Persistent Headache
Randolph W. Evans and Tad D. Seifert
Volume 51, No. 1, January 2011

Botulinum Toxin Type A as a Migraine Preventive Treatment
Stephen Silberstein, Ninan Mathew, Joel Saper and Stephen Jenkins, for the BOTOX Migraine Clinical Research Group
Volume 40, No. 6, June 2000

Migraine Diagnosis and Treatment: Results From the American Migraine Study II
Richard B. Lipton, Seymour Diamond, Michael Reed, Merle L. Diamond and Walter F. Stewart
Volume 41, No. 7, July/August 2001

A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine
Roger K. Cady, Curtis P. Schreiber, John A.H. Porter, Andrew M. Blumenfeld and Kathleen U. Farmer
Volume 51, No. 1, January 2011

One Hundred Years of Migraine Research: Major Clinical and Scientific Observations From 1910 to 2010
Peer C. Tfelt-Hansen and Peter J. Koehler
Volume 51, No. 5, May 2011

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse, Sheena K. Aurora, Stephen D. Silberstein, Richard B. Lipton, Hans-Christoph Diener and Mitchell F. Brin
Volume 50, No. 6, June 2010

Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
Andrew Blumenfeld, Stephen D. Silberstein, David W. Dodick, Sheena K. Aurora, Catherine C. Turkel and William J. Binder
Volume 50, No. 9, October 2010

Search the Site

Search

 

Site Adverts

  

 

 Follow ahshq on Twitter